Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1,091,129,524
-
Total 13F shares
-
10,842,196
-
Share change
-
+487,680
-
Total reported value
-
$231,479,000
-
Price per share
-
$21.35
-
Number of holders
-
35
-
Value change
-
+$10,475,130
-
Number of buys
-
21
-
Number of sells
-
11
Institutional Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q1 2018
As of 31 Mar 2018,
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,842,196 shares.
The largest 10 holders included
FMR LLC, GILDER GAGNON HOWE & CO LLC, Myriad Asset Management Ltd., PRICE T ROWE ASSOCIATES INC /MD/, ORBIMED ADVISORS LLC, Segantii Capital Management Ltd, Cormorant Asset Management, LP, Rock Springs Capital Management LP, Vivo Capital, LLC, and Marshall Wace North America L.P..
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.